help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Journal of Clinical Endocrinology & Metabolism Vol. 64, No. 1 32-36
doi:10.1210/jcem-64-1-32
Copyright © 1987 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BIZZARRO, A.
Right arrow Articles by IACONO, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BIZZARRO, A.
Right arrow Articles by IACONO, G.

Influence of Testosterone Therapy on Clinical and Immunological Features of Autoimmune Diseases Associated with Klinefelter’s Syndrome

A. BIZZARRO, G. VALENTINI, G. DI MARTINO, A. DAPONTE, A. DE BELLIS and G. IACONO

Semeiotica Medica II Chirurgia, Naples, Italy
Clinica Medica I Chirurgia, Naples, Italy
I Facoltà di Medkina e Chirurgia, Naples, Italy

Address requests for reprints to: Dr. Antonio Bizzarro, Viale Gramsci no. 22, 80122 Naples, Italy.

To examine the role of sex steroid hormones in the development of autoimmune diseases, we studied five patients with Klinefelter’s syndrome associated with autoimmune disease, three of whom had Sjögren’s syndrome (SS) and two of whom had systemic lupus erythematosus (SLE). Serum testosterone (T) and LH levels, antinuclear antibodies (ANA) and rheumatoid factor (RF) titers, erythrocyte sedimentation rate (ESR), hemolytic complement (CH50) levels, and peripheral T lymphocyte subsets (OKT3+, OKT4+, and OKT8+) were measured before treatment, after 60 days of placebo treatment, and after 60 days of oral T undecanoate (TU) treatment. Before treatment and after placebo, with respect to normal men, the patients had lower serum T and higher LH levels, lower percentages and absolute values of OKT3+ (total T lymphocytes) and OKT8+ (suppressor/cytotoxic T lymphocytes) cells, and, consequently, an increased OKT4/OKT8 ratio. Hemolytic complement (CH50) in serum was below normal in the two patients with SLE, while it was normal in the patients with SS. The ESR was above normal in all patients, and all had high titers of ANA and RF. After TU therapy, serum T levels increased and LH levels decreased, but not to normal. OKT3+ and OKT8+ cells and the OKT4/OKT8 ratio became normal, and RF and ANA titers decreased. The CH50 level did not change in the SS patients, while it increased to normal in the two patients with SLE. The ESR decreased in all patients during therapy. Furthermore, after TU therapy, both the SS and SLE patients had a clinical remission of their autoimmune disease.

Our results indicate a therapeutic effect of T on autoimmune diseases in patients with hypogonadism and Klinefelter’s syndrome.

Received April 9, 1986.




This article has been cited by other articles:


Home page
 J EndocrinolHome page
J J Corrales, M Almeida, R Burgo, M T Mories, J M Miralles, and A Orfao
Androgen-replacement therapy depresses the ex vivo production of inflammatory cytokines by circulating antigen-presenting cells in aging type-2 diabetic men with partial androgen deficiency.
J. Endocrinol., June 1, 2006; 189(3): 595 - 604.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
S. T. Page, S. R. Plymate, W. J. Bremner, A. M. Matsumoto, D. L. Hess, D. W. Lin, J. K. Amory, P. S. Nelson, and J. D. Wu
Effect of medical castration on CD4+CD25+ T cells, CD8+ T cell IFN-{gamma} expression, and NK cells: a physiological role for testosterone and/or its metabolites
Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E856 - E863.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
A. J. Swerdlow, M. J. Schoemaker, C. D. Higgins, A. F. Wright, P. A. Jacobs, and on behalf of the UK Clinical Cytogenetics Group
Cancer Incidence and Mortality in Men with Klinefelter Syndrome: A Cohort Study
J Natl Cancer Inst, August 17, 2005; 97(16): 1204 - 1210.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
C J Malkin, P J Pugh, P D Morris, K E Kerry, R D Jones, T H Jones, and K S Channer
Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life
Heart, August 1, 2004; 90(8): 871 - 876.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. J. Malkin, P. J. Pugh, R. D. Jones, D. Kapoor, K. S. Channer, and T. H. Jones
The Effect of Testosterone Replacement on Endogenous Inflammatory Cytokines and Lipid Profiles in Hypogonadal Men
J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3313 - 3318.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
B. A. L. Crawford, P. Y. Liu, M. T. Kean, J. F. Bleasel, and D. J. Handelsman
Randomized Placebo-Controlled Trial of Androgen Effects on Muscle and Bone in Men Requiring Long-Term Systemic Glucocorticoid Treatment
J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3167 - 3176.
[Abstract] [Full Text] [PDF]

Home page
 QJMHome page
C.J. Malkin, P.J. Pugh, T.H. Jones, and K.S. Channer
Testosterone for secondary prevention in men with ischaemic heart disease?
QJM, July 1, 2003; 96(7): 521 - 529.
[Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
M Osman
Therapeutic implications of sex differences in asthma and atopy
Arch. Dis. Child., July 1, 2003; 88(7): 587 - 590.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
J. Visootsak, M. Aylstock, and J. M. Graham Jr
Kilnefelter Syndrome and Its Variants: An Update and Review for the Primary Pediatrician
Clinical Pediatrics, December 1, 2001; 40(12): 639 - 651.
[Abstract] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. L. Krenzer, M. Reza Dana, M. D. Ullman, J. M. Cermak, D. B. Tolls, J. E. Evans, and D. A. Sullivan
Effect of Androgen Deficiency on the Human Meibomian Gland and Ocular Surface
J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4874 - 4882.
[Abstract] [Full Text]

Home page
 LupusHome page
C C Mok and C S Lau
Profile of sex hormones in male patients with systemic lupus erythematosus
Lupus, May 1, 2000; 9(4): 252 - 257.
[Abstract] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. J. Giltay, J. C. M. Fonk, B. M. E. von Blomberg, H. A. Drexhage, C. Schalkwijk, and L. J. G. Gooren
In Vivo Effects of Sex Steroids on Lymphocyte Responsiveness and Immunoglobulin Levels in Humans
J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1648 - 1657.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
Z. Yesilova, M. Ozata, I. H. Kocar, M. Turan, A. Pekel, A. Sengul, and I. C. Ozdemír
The Effects of Gonadotropin Treatment on the Immunological Features of Male Patients with Idiopathic Hypogonadotropic Hypogonadism
J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 66 - 70.
[Abstract] [Full Text]

Home page
 Arch Intern MedHome page
C. M. Smyth and W. J. Bremner
Klinefelter Syndrome
Arch Intern Med, June 22, 1998; 158(12): 1309 - 1314.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
C. J. Bagatell and W. J. Bremner
Androgens in Men -- Uses and Abuses
N. Engl. J. Med., March 14, 1996; 334(11): 707 - 715.
[Full Text] [PDF]

Home page
 LupusHome page
R.G. Lahita
Sex Steroids and SLE: Metabolism of Androgens to Estrogens
Lupus, May 1, 1992; 1(3): 125 - 127.
[PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1987 by The Endocrine Society